Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 428-410-9 | CAS number: 67014-36-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1998-06-08 - 1998-07-06
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP and guideline compliant study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 998
- Report date:
- 1998
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
- Version / remarks:
- adopted 27 July 1995
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.7 (Repeated Dose (28 Days) Toxicity (Oral))
- Version / remarks:
- adopted September 1996
- Deviations:
- no
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- -
- EC Number:
- 428-410-9
- EC Name:
- -
- Cas Number:
- 67014-36-2
- Molecular formula:
- C8 H9 N3 O
- IUPAC Name:
- 5-amino-6-methyl-2,3-dihydro-1H-1,3-benzodiazol-2-one
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, Sulzfeld, Germany
- Age at study initiation: approx. 6 weeks
- Housing: group housing of 5 animals per sex
- Diet: standard pelleted laboratory animal diet, ad libitum (Carfil Quality BVBA, Oud-Turnhout, Belgium)
- Water: tap water, ad libitum
- Acclimation period: at least 5 days before treatment
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21
- Humidity (%): 50
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- propylene glycol
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS:
Formulations (w/w) were prepared daily within 4 hours prior to dosing. Adjustment was made for specific gravity of vehicle.
VEHICLE
- Justification for use and choice of vehicle: Due to trial formulations performed at NOTOX B.V.
- Amount of vehicle (if gavage): 5 mL/kg bw - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Samples were analysed using HPLC/UV. Test substance formulations in propylene glycol were noted as stable for at least 4 hours and formed a homogeneous suspension at the concentrations tested. Analysis of the accuracy of dose preparations revealed values within the range of 98% to 104% of nominal, which was considered to represent an acceptable level of accuracy for formulations of this type.
Accuracy test: All formulations prepared on 10-06-98 were analysed for test substance concentration.
Homogeneity test: The formulations of groups 2 and 4 prepared on 10-06-98 were tested for homogeneity.
Stability test: The formulations of groups 2 and 4 prepared on 10-06-98 were analysed immediately after preparation and after 4 hours storage at ambient temperature.
Samples were analysed using HPLC/UV. - Duration of treatment / exposure:
- 28 days
- Frequency of treatment:
- daily
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 3, 15, 75 mg/kg bw/d
Basis:
actual ingested
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- - Dose selection rationale: Dose levels were selected on the basis of a 5-day dose range finding study.
- Positive control:
- No
Examinations
- Observations and examinations performed and frequency:
- DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: Once prior to start of treatment and on days 8, 15, 22 and 28
BODY WEIGHT: Yes
- Time schedule for examinations: On days 1, 8, 15, 22 and 28
FOOD CONSUMPTION: Yes
- Food consumption for each animal determined: weekly
HAEMATOLOGY: Yes
- Time schedule for collection of blood: prior to post mortem examination
- Anaesthetic used for blood collection: Yes (ether vapour)
- Animals fasted: Yes
- How many animals: all
- The following Parameters were examined: Erythrocyte count/RBC, Haemoglobin/HB, Haematocrit/HCT, Mean corpuscular volume/MCV, Mean corpuscular haemoglobin/MCH, Mean corpuscular haemoglobin concentration/MCHC, Platelet count, Red cell distribution width/RDW, Total leucocyte count/WBC, Differential leucocyte count/SEG (Neutrophils), EO (Eosinophils), BASO (Basophils), LYMPH (Lymphocytes), MONO (Monocytes)Prothrombin time/PT, Partial thromboplastin time/PTT
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: prior to post mortem examination
- Animals fasted: Yes
- How many animals: all
- The following Parameters were examined: Alanine aminotransferase/(ALAT/GPT), Aspartate aminotransferase/(ASAT/GOT), Bilirubin (total/BILI T), Cholesterol (total/CHOLEST.T), Creatinine, Glucose, Urea, Protein (total/PROTEIN T), Protein (albumin/ALBUMIN), Alkaline phosphatase/ALP, Sodium, Potassium, Chloride, Calcium, Phosphorus/INORG. PHOSPH
NEUROBEHAVIOURAL EXAMINATION: Yes
- Time schedule for examinations: during week 4
- Dose groups that were examined: all
- Battery of functions tested: sensory activity / grip strength / motor activity - Sacrifice and pathology:
- GROSS PATHOLOGY
All animals surviving to the end of the observation period were deeply anaesthetised using ether vapour and subsequently exsanguinated. All animals assigned to the study were necropsied and descriptions of all macroscopic abnormalities recorded. Samples of the following tissues and organs were collected from all animals at necropsy and fixed in a 4% formaldehyde solution: Adrenal glands, Aorta, Brain, Caecum, (Cervix), (Clitoral gland), Colon, Duodenum, Epididymides, (Eyes with optic nerve and Harderian gland), (Female mammary gland area), (Femur including joint), Heart, Ileum, Jejunum, Kidneys, (Larynx), (Lacrimal gland, exorbital), Liver, Lung, infused with formalin, Lymph nodes - mandibular, mesenteric, (Nasopharynx), Oesophagus, Ovaries, Pancreas, Peyer's patches (jejunum, ileum) if detectable, Pituitary gland, (Preputial gland), Prostate gland, Rectum, (Salivary glands - mandibular, sublingual), Sciatic nerve, (Seminal vesicles), (Skeletal muscle), (Skin), Spinal cord -cervical, midthoracic, lumbar, Spleen, Sternum with bone marrow, Stomach, Testes, Thymus, Thyroid including parathyroid, (Tongue), Trachea, Urinary bladder, Uterus, (Vagina), All gross lesions
HISTOPATHOLOGY: Yes with all the above collected organs. - Statistics:
- The following statistical methods were used to analyse the data:
- Univariate one-way analysis of variance was used to assess the significance of intergroup differences.
- If the variables could be assumed to follow a normal distribution, the Dunnett-test (many-to-one t-test) based on a pooled variance estimate was applied for the comparison of the treated groups and the control groups for each sex.
- The Steel-test (many-to-one rank test) was applied when the data could not be assumed to follow a normal distribution.
All tests were two-sided and in all cases p < 0.05 was accepted as the lowest level of significance. Group means were calculated for continuous data and medians were calculated for discrete data (scores) in the summary tables. Test statistics were calculated on the basis of exact values for means and pooled variances. Individual values, means and standard deviations may have been rounded off before printing. Therefore, two groups may display the same printed means for a given parameter, yet display different test statistics values.
Results and discussion
Results of examinations
- Details on results:
- CLINICAL SIGNS AND MORTALITY
No mortality occurred during the study. There were no clinical signs of toxicity or behavioural changes over the 28-day observation period that were considered to be related to treatment. Incidental findings that were noted among treated and control animals included alopecia, red or brown staining of various parts of the body, a wound, scabs. The incidence of these findings remained within the range expected for group housed rats used in this type of study and were considered of no toxicological significance. The maculate erythema on the tail, noted in all females of the low dose group during the first week of the study, was considered to be caused by biting among the animals. Since this finding was present prior to commencement of treatment it was not taken into account for interpretation. Salivation was observed among control and treated animals. This sign is often noted in rats of this age and strain following oral gavage and considered to be related to multiple intra-oesophageal intubation and/or the taste of the test substance. Therefore, this finding was considered not to be a sign of systemic toxicity.
BODY WEIGHT AND WEIGHT GAIN
Reduced body weight gain, and to a lesser degree lower body weights, were observed in the females receiving 75 mg/kg bw/day from day 15 onwards. Statistically significant mean values for body weight gain were achieved on days 22 and 28 for these animals, when compared to control group values. Over the last week of treatment, the average body weight gain for the females receiving 15 mg/kg bw/day was also slightly lower then of controls (not statistically significant). Body weights and body weight gain of treated males remained in the same range as controls over the 4-week study period.
FOOD CONSUMPTION
There were no marked differences (< 10%) in food consumption before or after allowance for body weight between treated and control animals.
HAEMATOLOGY
Haematological parameters of treated rats were considered not to have been affected by treatment. The statistically significant difference in differential monocytes count arising between controls and males receiving 15 mg/kg bw/day was considered to have arisen by chance based on the absence of a dose response relationship.
CLINICAL CHEMISTRY
There were no differences noted between control and treated rats that were considered to be related to treatment with the test substance. The decreased values for alanine aminotransferase (ALAT) and aspartate aminotransferase (ALAT) activity, achieving a level of statistical significance in males and females receiving 15 mg/kg bw/day, respectively, were considered of no toxicological significance, based on the absence of a treatment-related distribution or corroborative findings in the opposite sex. Moreover, a decrease in the enzyme levels ALAT and ASAT is considered to be of no biological relevance. The minor statistically significant difference in plasma chloride concentration arising between controls and females receiving 75 mg/kg bw/day was considered to have arisen as a result of a slightly high control value (and small standard deviation). Since all values were well within the range of historical background data no toxicological significance was attached to this finding.
NEUROBEHAVIOUR
The variation in motor activity did not indicate a relation with treatment. No abnormalities were observed in any of the other functional observation tests. In two females of the 75 mg/kg/day dose group, animal No. 37 and No. 39, an increased and decreased motor activity was recorded, respectively, when compared to the activity recorded for the other animals in the study. Based on the absence of any corroborative findings in these animals and of a tendency within the dose group, no toxicological significance was attached to these findings.
ORGAN WEIGHTS
Organ weights and organ weights:body weight ratios of treated animals were considered to be similar to those of control animals.
GROSS PATHOLOGY
Macroscopic observations at necropsy did not reveal any alterations that were considered to have arisen as a result of treatment. The macroscopic findings noted were considered to be spontaneous in nature and within the range of biological variation for rats of this age and strain. The distribution of the findings did not distinguish treated animals from the controls.
HISTOPATHOLOGY: NON-NEOPLASTIC
There were no microscopic findings recorded which could be attributed to treatment with the test substance. All microscopic findings were within the range of background pathology encountered in Wistar rats of this age and strain and occurred at similar incidences and severity in both control and treated rats.
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- 75 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Body weight gain
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.